Invention Grant
- Patent Title: Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
-
Application No.: US17211119Application Date: 2021-03-24
-
Publication No.: US11260061B2Publication Date: 2022-03-01
- Inventor: Michael A. Gosselin , Jin-Wang Lai , Gopi M. Venkatesh
- Applicant: Ellodi Pharmaceuticals, L.P.
- Applicant Address: US NJ Lawrenceville
- Assignee: Ellodi Pharmaceuticals, L.P.
- Current Assignee: Ellodi Pharmaceuticals, L.P.
- Current Assignee Address: US NJ Lawrenceville
- Agency: Cooley, LLP
- Main IPC: A61K31/56
- IPC: A61K31/56 ; A61K9/00 ; A61K9/20 ; A61J3/10 ; A61K45/06 ; B29C43/00

Abstract:
The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention as orally disintegrating tablets comprising a topically active corticosteroid adsorbed onto a pharmaceutically acceptable carrier such as silicified microcrystalline cellulose.
Public/Granted literature
- US20210205328A1 CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS Public/Granted day:2021-07-08
Information query